A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD

INTRODUCTION: The Fostair® 100/6 (BDP/FF) pressurized metered-dose inhaler, delivering an extrafine formulation, is licensed for asthma and COPD in the UK. However, its real-life effectiveness for COPD has not been evaluated. This study compared the clinical effectiveness of BDP/FF against other lic...

Descripción completa

Detalles Bibliográficos
Autores principales: Ming, Simon Wan Yau, Haughney, John, Ryan, Dermot, Small, Iain, Lavorini, Federico, Papi, Alberto, Singh, Dave, Halpin, David M G, Hurst, John R, Patel, Shishir, Ochel, Matthias, Kocks, Janwillem, Carter, Victoria, Hardjojo, Antony, Price, David B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705280/
https://www.ncbi.nlm.nih.gov/pubmed/33273812
http://dx.doi.org/10.2147/COPD.S263745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705280/
https://www.ncbi.nlm.nih.gov/pubmed/33273812
http://dx.doi.org/10.2147/COPD.S263745

Ejemplares similares